Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

Formation of Muscle Fibers from Myoblasts

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes.

ESC heart failure·2020

Same author

First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery.

JACC. Cardiovascular interventions·2018

Same author

Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.

European heart journal·2018

Same author

New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.

European journal of heart failure·2017

Same author

Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases.

European journal of heart failure·2017

Same author

Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.

European heart journal·2016

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Isolation, Culture, and Transplantation of Muscle Satellite Cells

Isolation, Culture, and Transplantation of Muscle Satellite Cells

Published on: April 8, 2014

Myocyte replacement therapy: skeletal myoblasts.

Warren Sherman¹

¹Division of Cardiology, Department of Medicine, College of Physicians & Surgeons, Columbia University, New York, NY, USA. ws2157@columbia.edu

Cell Transplantation

|February 26, 2008

Summary

This summary is machine-generated.

Skeletal myoblasts show promise for treating heart disease by improving ventricular function. Ongoing clinical trials will determine their future role in cardiac regeneration therapy.

More Related Videos

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

Related Experiment Videos

Last Updated: Jul 7, 2026

Isolation, Culture, and Transplantation of Muscle Satellite Cells

Isolation, Culture, and Transplantation of Muscle Satellite Cells

Published on: April 8, 2014

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

Area of Science:

Regenerative Medicine
Cardiovascular Biology
Cell Therapy

Background:

Skeletal myoblasts are muscle progenitors with self-renewal capacity and positive cardiac effects.
They can be safely administered to diseased myocardium, offering a distinct advantage over other myogenic cells.
Previous clinical studies show modest improvements in ventricular function and patient status.

Purpose of the Study:

To evaluate the efficacy and safety of skeletal myoblasts in cardiac regeneration.
To assess the potential of skeletal myoblasts for treating chronic myocardial disease and heart failure.
To investigate the future clinical role of skeletal myoblasts in cardiovascular medicine.

Main Methods:

Autologous skeletal myoblasts are procured and administered into the myocardium.
Clinical studies, including randomized placebo-controlled trials (e.g., MYOHEART, MAGIC, MARVEL), are evaluating outcomes.
Ongoing research focuses on engineered myoblasts for enhanced therapeutic efficacy.

Main Results:

Consistent modest improvements in ventricular function and clinical status have been reported in chronic myocardial disease patients.
Data from the MYOHEART trial are under evaluation.
Larger, randomized trials are currently underway to confirm these findings.

Conclusions:

Skeletal myoblasts demonstrate potential as a cell therapy for cardiac repair.
Their ease of procurement and safe administration make them a viable option.
The definitive role of skeletal myoblasts in clinical practice awaits results from ongoing randomized trials and advancements in cell engineering.